Elevated adiponectin is associated with poor outcome in children with biliary atresia

Wanvisa Udomsinprasert 1 , Sittisak Honsawek 2 , Wilai Anomasiri 1 , Voranush Chongsrisawat 3 , Paisarn Vejchapipat 4  and Yong Poovorawan 3
  • 1 Program in Medical Sciences, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
  • 2 MD, PhD, Program in Medical Sciences, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand
  • 3 Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
  • 4 Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

Abstract

Background: Biliary atresia (BA) is a severe neonatal liver disease characterized by progressive fibrosclerotic obliteration of the extrahepatic biliary tree.

Objective: We compared serum adiponectin in post Kasai BA patients with healthy controls and associate adiponectin with clinical outcomes of BA patients.

Methods: One hundred and six postoperative BA patients and 40 controls were recruited in this study. BA patients were categorized into two groups based on their serum total bilirubin (TB) levels (TB<2 mg/dL, no jaundice vs. TB ≥2 mg/dL, persistent jaundice) and alanine aminotransferase (ALT) levels (ALT<45 IU/L, normal ALT vs. ALT ≥45 IU/L, elevated ALT). Serum adiponectin levels were determined by enzyme-linked immunosorbent assay.

Results: BA patients had higher serum adiponectin levels than healthy controls (172.8±90.9 vs. 93.9±53.5 ng/mL, p <0.001). Serum adiponectin levels were elevated in BA patients with jaundice compared to those without jaundice (229.6±89.0 vs. 139.7±74.5 ng/mL, p <0.001). Furthermore, BA patients with elevated ALT displayed significantly higher levels of serum adiponectin than those with normal ALT (187.2±91.8 vs. 117.6±62.8 ng/mL, p <0.001). Additionally, BA patients with portal hypertension had substantially higher serum adiponectin than those without portal hypertension and a poorer clinical outcome (207.0±90.2 vs. 118.5±62.1 ng/mL, p <0.001).

Conclusions: Increased serum adiponectin was associated with a poor outcome in postoperative BA patients. Serum adiponectin might be utilized as a biochemical indicator reflecting the deterioration of liver function and poorer outcome in BA after Kasai operation.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Hartley JL, Davenport M, Kelly DA. Biliary atresia.

  • Lancet. 2009; 374:1704-13.

  • 2. Bassett MD, Murray KF. Biliary atresia: recent progress. J Clin Gastroenterol. 2008; 42:720-9.

    • Crossref
    • Export Citation
  • 3. Erlichman J, Hohlweg K, Haber BA. Biliary atresia: how medical complications and therapies impact outcome. Expert Rev Gastroenterol Hepatol. 2009; 3: 425-34.

    • Crossref
    • Export Citation
  • 4. A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, Mohsen N, El-Karaksy H, Hassanein B, et al. Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol. 2003; 15:447.

    • Crossref
    • Export Citation
  • 5. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996; 271:10697-703.

  • 6. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.

  • Trends Endocrinol Metab. 2002; 13:84-9.

  • 7. Shimizu A, Takamura T, Matsuzawa N, Nakamura S, Nabemoto S, Takeshita Y, et al. Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line. Metabolism. 2007; 56:1478-85.

    • Crossref
    • Export Citation
  • 8. Bertolani C, Marra F. Role of adipocytokines in hepatic fibrosis. Curr Pharm Des. 2010; 16:1929-40.

    • Crossref
    • Export Citation
  • 9. Marra F, Bertolani C. Adipokines in liver diseases.

  • Hepatology. 2009; 50:957-69.

  • 10. Honsawek S, Chongsrisawat V, Praianantathavorn K, Theamboonlers A, Poovorawan Y. Elevation of Serum Galectin-3 and Liver Stiffness Measured by Transient Elastography in Biliary Atresia. Eur J Pediatr Surg. 2011; 21:250-4.

    • Crossref
    • Export Citation
  • 11. Honsawek S, Praianantathavorn K, Chongsrisawat V, Vejchapipat P, Theamboonlers A, Poovorawan Y.

  • High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia. Pediatr Surg Int. 2011; 27:681-7.

    • PubMed
    • Export Citation
  • 12. Honsawek S, Chayanupatkul M, Chongsrisawat V, Vejchapipat P, Poovorawan Y. Increased osteopontin and liver stiffness measurement by transient elastography in biliary atresia. World J Gastroenterol. 2010; 16:5467-73.

    • Crossref
    • Export Citation
  • 13. Chayanupatkul M, Honsawek S, Vejchapipat P, Chongsrisawat V, Poovorawan Y. Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia. Eur J Pediatr Surg. 2009; 19:246-50.

    • Crossref
    • Export Citation
  • 14. Honsawek S, Chayanupatkul M, Chongsrisawat V, Theamboonlers A, Praianantathavorn K, Udomsinprasert W, et al. Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia. BMC Gastroenterol. 2011; 11:16.

    • Crossref
    • Export Citation
  • 15. Liu CJ, Chen PJ, Lai MY, Liu CH, Chen CL, Kao JH, et al. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection. Hepatol Int. 2009; 3:364-70.

    • Crossref
    • Export Citation
  • 16. Arano T, Nakagawa H, Tateishi R, Ikeda H, Uchino K, Enooku K, et al. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int J Cancer. 2010;129:2226-35.

    • Crossref
    • Export Citation
  • 17. Baranova A, Jarrar MH, Stepanova M, Johnson A, Rafiq N, Gramlich T, et al. Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C. Digestion. 2011; 83: 32-40.

  • 18. Latif HA, Assal HS, Mahmoud M, Rasheed WI. Role of serum adiponectin level in the development of liver cirrhosis in patients with hepatitis C virus. Clin Exp Med. 2011; 11:123-9.

    • Crossref
    • Export Citation
  • 19. Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY.

  • Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009; 24:233-7

    • PubMed
    • Export Citation
OPEN ACCESS

Journal + Issues

Search